1. Home
  2. PFLT vs BIOA Comparison

PFLT vs BIOA Comparison

Compare PFLT & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PennantPark Floating Rate Capital Ltd.

PFLT

PennantPark Floating Rate Capital Ltd.

HOLD

Current Price

$8.90

Market Cap

805.6M

Sector

Finance

ML Signal

HOLD

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

HOLD

Current Price

$17.92

Market Cap

757.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFLT
BIOA
Founded
2010
2015
Country
United States
United States
Employees
N/A
62
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
805.6M
757.0M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
PFLT
BIOA
Price
$8.90
$17.92
Analyst Decision
Buy
Strong Buy
Analyst Count
6
6
Target Price
$10.50
$51.50
AVG Volume (30 Days)
898.6K
346.8K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
14.12%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.16
$720.93
Revenue Next Year
N/A
N/A
P/E Ratio
$24.14
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.68
$3.79
52 Week High
$10.88
$24.00

Technical Indicators

Market Signals
Indicator
PFLT
BIOA
Relative Strength Index (RSI) 55.18 51.74
Support Level $8.47 $15.59
Resistance Level $9.46 $18.65
Average True Range (ATR) 0.19 1.25
MACD 0.01 0.11
Stochastic Oscillator 48.10 43.39

Price Performance

Historical Comparison
PFLT
BIOA

About PFLT PennantPark Floating Rate Capital Ltd.

PennantPark Floating Rate Capital Ltd is a closed-end, externally managed, non-diversified investment company. Its investment objectives are to generate both current income and capital appreciation by investing in Floating Rate Loans and other investments made to U.S. middle-market companies. The company believes that Floating Rate Loans to U.S. middle-market companies offer attractive risk-reward to investors due to the limited amount of capital available for such companies and the potential for rising interest rates. The company generates revenue in the form of interest income on the debt securities and dividends.

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

Share on Social Networks: